Abstract
The underlying pathogenesis of cardiovascular disease is the formation of occlusive thrombi. While many well-defined animal models recapitulate the process of intravascular thrombosis, there is a need for validated ex vivo models of occlusive thrombus formation. Using the force of gravity to provide a constant pressure gradient, we designed and validated an ex vivo model of thrombosis. Times to occlusion on a collagen matrix in our model were within the range of occlusion times observed in murine thrombosis models. Prolongation of time to occlusion in the presence of platelet αIIbβ3 antagonists or inhibitors to thrombin or activated factor X is in agreement with established mechanisms of thrombus formation. The use of this model may be expanded to characterize the mechanisms of thrombosis and to determine the efficacy of pharmacological agents designed to prevent occlusive thrombus formation.
Similar content being viewed by others
Abbreviations
- ECM:
-
Extracellular matrix
- TF:
-
Tissue factor
- PBS:
-
Phosphate buffered saline
- BSA:
-
Bovine serum albumin
- APC:
-
Activated protein C
References
Berny, M. A., T. C. White, E. I. Tucker, L. A. Bush-Pelc, E. Di Cera, A. Gruber, and O. J. McCarty. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist. Arterioscler. Thromb. Vasc. Biol. 28:329–334, 2008.
Denis, C. V., and D. D. Wagner. Platelet adhesion receptors and their ligands in mouse models of thrombosis. Arterioscler. Thromb. Vasc. Biol. 27:728–739, 2007.
Gorog, P. A new, ideal technique to monitor thrombolytic therapy. Angiology 37:99–105, 1986.
Gorog, P., and A. Ahmed. Haemostatometer: a new in vitro technique for assessing haemostatic activity of blood. Thromb. Res. 34:341–357, 1984.
Harker, L. A., A. B. Kelly, and S. R. Hanson. Experimental arterial thrombosis in nonhuman primates. Circulation 83:IV41–IV55, 1991.
Heemskerk, J. W., E. M. Bevers, and T. Lindhout. Platelet activation and blood coagulation. Thromb. Haemost. 88:186–193, 2002.
Kratzer, M. A., and G. V. Born. Simulation of primary haemostasis in vitro. Haemostasis 15:357–362, 1985.
McCarty, O. J., J. P. Abulencia, S. A. Mousa, and K. Konstantopoulos. Evaluation of platelet antagonists in in vitro flow models of thrombosis. Methods Mol. Med. 93:21–34, 2004.
Muga, K. M., L. G. Melton, and D. A. Gabriel. A flow dynamic technique used to assess global haemostasis. Blood Coagul. Fibrinolysis 6:73–78, 1995.
Phillips, D. R., P. B. Conley, U. Sinha, and P. Andre. Therapeutic approaches in arterial thrombosis. J. Thromb. Haemost. 3:1577–1589, 2005.
Renne, T., B. Nieswandt, and D. Gailani. The intrinsic pathway of coagulation is essential for thrombus stability in mice. Blood Cells Mol. Dis. 36:148–151, 2006.
Renne, T., M. Pozgajova, S. Gruner, K. Schuh, H. U. Pauer, P. Burfeind, D. Gailani, and B. Nieswandt. Defective thrombus formation in mice lacking coagulation factor XII. J. Exp. Med. 202:271–281, 2005.
Tucker, E. I., U. M. Marzec, T. C. White, S. Hurst, S. Rugonyi, O. J. McCarty, D. Gailani, A. Gruber, and S. R. Hanson. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 113:936–944, 2009.
White, T. C., M. A. Berny, E. I. Tucker, R. T. Urbanus, P. G. De Groot, J. A. Fernandez, J. H. Griffin, A. Gruber, and O. J. McCarty. Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. J. Thromb. Haemost. 6:995–1002, 2008.
Acknowledgments
Supported by American Heart Association Grants 09PRE2230117 (M.A.B.), 0910025G (T.C.W.), and 09GRNT2150003 (O.J.T.M.). M.A.B. and T.C.W. are ARCS scholars; T.C.W. is a Vertex Scholar; I.A.P. is the recipient of a Johnson scholarship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berny, M.A., Patel, I.A., White-Adams, T.C. et al. Rational Design of an Ex Vivo Model of Thrombosis. Cel. Mol. Bioeng. 3, 187–189 (2010). https://doi.org/10.1007/s12195-010-0103-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12195-010-0103-5